Prevalence of Chagas disease among Latin American immigrants in non-endemic countries: an updated systematic review and meta-analysis
This study was funded by the World Heart Federation, through a research collaboration with Novartis Pharma AG.
Authors
- Bruno Ramos Nascimento (ORCID: https://orcid.org/0000-0002-5586-774X)
- Francisco Rogerlândio Martins‐Melo
- Pau Bosch‐Nicolau (ORCID: https://orcid.org/0000-0002-7435-1829)
- Caroline Demacq (ORCID: https://orcid.org/0009-0003-5823-1135)
- Ísis Eloah Machado (ORCID: https://orcid.org/0000-0002-4678-2074)
- Monica Quijano
- Israel Molina (ORCID: https://orcid.org/0000-0001-6642-7515)
- Yvonne Geissbühler (ORCID: https://orcid.org/0000-0001-8528-6818)
- Ewerton Cousin (ORCID: https://orcid.org/0000-0003-3455-8865)
- Jonathan F Mosser (ORCID: https://orcid.org/0000-0001-9093-3186)
- Gisele Nepomuceno de Andrade (ORCID: https://orcid.org/0000-0003-0433-8351)
- Pablo Perel (ORCID: https://orcid.org/0000-0002-2342-301X)
- Antônio Luiz Pinho Ribeiro (ORCID: https://orcid.org/0000-0002-2740-0042)
- Maria Elisabete Marques Rodrigues
Institutions
- Universidade Federal de Ouro Preto (BR)
- Universidade Federal de Minas Gerais (BR)
- Hebron University (PS)
- Novartis (Switzerland) (CH)
- University of Washington (US)
- Instituto de Salud Carlos III (ES)
- Instituto Federal de Educação, Ciência e Tecnologia do Ceará (BR)
- Institute for Health Metrics and Evaluation (US)
- Hospital Madre Teresa (BR)
- London School of Hygiene & Tropical Medicine (GB)
- Centro de Investigación Biomédica en Red (ES)
- Vall d'Hebron Hospital Universitari (ES)
- Hospital das Clínicas da Universidade Federal de Minas Gerais (BR)
- World Heart Federation (CH)
Publication Details
- Journal
- The Lancet Regional Health - Europe
- Published
- 2024-09-06
- DOI
- https://doi.org/10.1016/j.lanepe.2024.101040
- Citations
- 17
- Primary Topic
- Trypanosoma species research and implications
- Type
- article
- Field-Weighted Citation Impact
- 6.57
Funders
- Universidade Federal de Minas Gerais
- World Heart Federation
- Novartis Pharma